会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • BIFURCATION BLOOD VESSEL STENT
    • GEGABELTERBLUTGEFÄSS-STENT
    • EP2638882A1
    • 2013-09-18
    • EP11839759.5
    • 2011-08-16
    • Shanghai MicroPort Medical (Group) Co., Ltd.
    • CAI, XuZHANG, DadongWANG, ChangchunTANG, ZhirongLUO, QiyiCHANG, Zhaohua
    • A61F2/82
    • A61F2/82A61F2/856A61F2/915A61F2002/067A61F2002/91575A61F2250/0096A61F2250/0098
    • A stent for a bifurcated vessel comprises a stent body (1) having two open ends (101,102), wherein at least one of the open ends (101,102) of the stent body is a wedge structure, a second opaque marker (6) is provided on the two ends of the slant long axis of the wedge structure, the stent body (1) is provided with two first opaque markers (5), and the connecting line between the two first opaque markers (5) is parallel to the slant of the wedge structure. Since the connecting line between the two first opaque markers (5) on the stent for a bifurcated vessel is parallel to the slant of the wedge structure, when the two first opaque markers (5) overlap with each other, the slant of the wedge structure of the stent for a bifurcated vessel is precisely positioned during implantation so that the slant of the wedge structure of the stent for a bifurcated vessel fits the slant at the blood vessel bifurcation site.
    • 用于分叉血管的支架包括具有两个开放端(101,102)的支架主体(1),其中支架主体的开口端(101,102)中的至少一个是楔形结构,提供第二不透明标记(6) 在楔形结构的倾斜长轴的两端上,支架主体(1)设置有两个第一不透明标记(5),两个第一不透明标记(5)之间的连接线平行于 楔形结构。 由于用于分叉血管的支架上的两个第一不透明标记(5)之间的连接线平行于楔形结构的倾斜,所以当两个第一不透明标记(5)彼此重叠时,楔形结构的倾斜 用于分叉血管的支架在植入期间被精确定位,使得用于分叉血管的支架的楔形结构的斜面适合于血管分叉部位处的倾斜。
    • 9. 发明公开
    • INTERVENTION MEDICAL DEVICE AND PREPARATION THEREOF
    • PRODUKTEFÜRMEDISINISCHE EINGRIFFE UND DEREN HERSTELLUNG
    • EP2581099A1
    • 2013-04-17
    • EP11795174.9
    • 2011-06-13
    • Shanghai MicroPort Medical (Group) Co., Ltd.
    • LI, JunfeiHU, XiLE, ChengjunWANG, DaweiHUANG, PengTANG, ZhirongLUO, QiyiCHANG, Zhaohua
    • A61L27/28A61F2/06A61L27/44
    • A61L27/34A61L27/54A61L31/10A61L31/16A61L2300/42
    • The present invention discloses an interventional medical device and methods of making the same. At least one coating layer is disposed on the outer surface of the interventional medical device and the material of the outmost layer of the coating layer is a sulfonate group-containing polymer. In the present invention, the material of the outmost layer of the interventional medical device is a sulfonate group-containing polymer. The polymer is endowed with a same surface property as that of heparin in addition to appropriate hydrophilicity due to the presence of the sulfonate group. After the interventional medical device is implanted into the human body, a hydrophilic surface is formed on the outer surface of the interventional medical device which is also negatively charged in the body fluid. Therefore, cells can easily adhere and grow on the outer surface thereof as a result of the enhanced cell compatibility. Furthermore, due to a surface property that is the same as that of heparin, the material is provided with excellent anticoagulant properties which inhibit the thrombosis and lower down the incidence rate of post-operational complications.
    • 本发明公开了一种介入医疗装置及其制造方法。 至少一个涂层设置在介入医疗装置的外表面上,涂层的最外层的材料是含磺酸基的聚合物。 在本发明中,介入医疗装置的最外层的材料是含磺酸基的聚合物。 由于存在磺酸盐基,除了适当的亲水性之外,聚合物具有与肝素相同的表面性质。 在将介入医疗装置植入人体后,在介入医疗装置的外表面上形成亲水性表面,其也在体液中带负电。 因此,由于增强的细胞相容性,细胞可以容易地附着和生长在其外表面上。 此外,由于与肝素相同的表面性质,该材料具有优异的抗凝血性能,其抑制血栓形成并降低术后并发症的发生率。